Oxidized low-density lipoprotein and 15-deoxy-Δ12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells

被引:52
|
作者
Ceaser, EK
Ramachandran, A
Levonen, AL
Darley-Usmar, VM
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA
关键词
oxidized lipid; reactive oxygen and nitrogen species; peroxisome proliferator-activated receptors; 4-hydroxynonenal;
D O I
10.1152/ajpheart.00508.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidized lipids are capable of initiating diverse cellular responses through both receptor-mediated mechanisms and direct posttranslational modification of proteins. Typically, exposure of cells to low concentrations of oxidized lipids induces cytoprotective pathways, whereas high concentrations result in apoptosis. Interestingly, mitochondria can contribute to processes that result in either cytoprotection or cell death. The role of antioxidant defenses such as glutathione in adaptation to stress has been established, but the potential interaction with mitochondrial function is unknown and is examined in this article. Human umbilical vein endothelial cells (HUVEC) were exposed to oxidized LDL (oxLDL) or the electrophilic cyclopentenone 15-deoxy-(Delta12,14)-PGJ(2) (15d-PGJ(2)). We demonstrate that complex I activity, but not citrate synthase or cytochrome-c oxidase, is significantly induced by oxLDL and 15d-PGJ(2). The mechanism is not clear at present but is independent of the induction of GSH, peroxisome proliferator-activated receptor (PPAR)-gamma, and PPAR-alpha. This response is dependent on the induction of oxidative stress in the cells because it can be prevented by nitric oxide, probucol, and the SOD mimetic manganese(III) tetrakis(4-benzoic acid) porphyrin chloride. This increased complex I activity appears to contribute to protection against apoptosis induced by 4-hydroxynonenal.
引用
收藏
页码:H2298 / H2308
页数:11
相关论文
共 50 条
  • [31] 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells
    Clay, CE
    Namen, AM
    Fonteh, AN
    Atsumi, G
    High, KP
    Chilton, FH
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01): : 23 - 32
  • [32] Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-γ:: Effect of 15-deoxy-Δ12,14-PGJ2 and troglitazone
    Lappas, M
    Permezel, M
    Georgiou, HM
    Rice, GE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10): : 4667 - 4672
  • [33] Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E2 and 15-deoxy-Δ12,14-PGJ2
    Wang, Pu
    Zhu, Fei
    Konstantopoulos, Konstantinos
    [J]. PLOS ONE, 2011, 6 (11):
  • [34] Response to letter by Tsikas et al. 15-deoxy-Δ12,14-PGJ2: An interesting but unapproachable pharmacological target? (vol 177, pg 307, 2014)
    Tsikas, Dimitrios
    Niemann, Jonas
    Beckmann, Bibiana
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 191 : 322 - 322
  • [35] 15-deoxy-Δ12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells
    Józkowicz, A
    Nigisch, A
    Winter, B
    Weigel, G
    Huk, I
    Dulak, J
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2004, 74 (1-4) : 11 - 28
  • [36] 15-Deoxy-Δ12,14-prostaglandin J2 inhibits the expression of fractalkine in endothelial cells
    Imaizumi, T
    Yoshida, H
    Satoh, K
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 310 - 310
  • [37] Peroxisome proliferator activator receptor-γ (PPARγ) ligands, 15-deoxy-Δ12,14-PGJ2 (15D-PGJ2) and ciglitazone, provide cardioprotection during reperfusion through different molecular mechanisms.
    Zingarelli, B
    Hake, PW
    O'Connor, M
    Burroughs, TJ
    Denenberg, A
    [J]. SHOCK, 2004, 21 : 62 - 62
  • [38] Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-?12,14-PGJ2 in fish granulocytes
    Gomez-Abellan, Victoria
    Perez-Oliva, Ana B.
    Cabas, Isabel
    Hermi, Fatma
    Arizcun, Marta
    Garcia-Moreno, Diana
    Sepulcre, Maria P.
    Mulero, Victoriano
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2022, 136
  • [39] 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells
    Chen, Siyan
    Liu, Chong
    Wang, Xiaoqian
    Li, Xiujin
    Chen, Yanling
    Tang, Nanhong
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 214 : 26 - 32
  • [40] Effects of 15-Deoxy-Δ12,14-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2+ T Cells
    Li, Haishan
    Pauza, C. David
    [J]. PLOS ONE, 2009, 4 (11):